Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — September 2015

Planlagt Fastgjort Låst Flyttet Genmab
2.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • dingleberryD Offline
    dingleberryD Offline
    dingleberry
    wrote on sidst redigeret af
    #2089

    det lille "s" står for om det er supplementary - dvs om der allerede er givet en approval fra FDAs side i en anden indikation

    1 Reply Last reply
    0
    • MadsSkjernM Offline
      MadsSkjernM Offline
      MadsSkjern
      wrote on sidst redigeret af
      #2090

      præcis. og OPdivos hurtige approval var i 2.indikation

      1 Reply Last reply
      0
      • dingleberryD Offline
        dingleberryD Offline
        dingleberry
        wrote on sidst redigeret af
        #2091

        så en sBLA burde alt andet lige være hurtigere end en BLA. Og pga produktionsprocessen vil en NDA være hurtigere end en BLA

        1 Reply Last reply
        0
        • dingleberryD Offline
          dingleberryD Offline
          dingleberry
          wrote on sidst redigeret af
          #2092

          Siden dara er en BLA vil den principielt være i den langsomme gruppe - modsat vil den blive hurtigere pga unmet need

          1 Reply Last reply
          0
          • dingleberryD Offline
            dingleberryD Offline
            dingleberry
            wrote on sidst redigeret af
            #2093

            Så vidt jeg kan gennemskue er Opdivo's godkendelse af BLA (den første gang) den hurtigste godkendelse - 3 måneder før pdufa

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #2094

              ... og så er vi henne ved juletid

              1 Reply Last reply
              0
              • G Offline
                G Offline
                gentogen
                wrote on sidst redigeret af
                #2095

                Conditional marketing authorisation allows for the early approval of a medicine on the basis of less complete clinical data than normally required, if the medicine addresses an unmet medical need and targets a seriously debilitating or life-threatening disease

                1 Reply Last reply
                0
                • G Offline
                  G Offline
                  gentogen
                  wrote on sidst redigeret af
                  #2096

                  Link Preview Image
                  Page or document not found | European Medicines Agency (EMA)

                  We are sorry, but the content you tried to access is unavailable at the link you used, which was either incorrect or out-of-date. To help you find what you are looking for, we have included some useful tips.

                  favicon

                  European Medicines Agency (EMA) (www.ema.europa.eu)

                  1 Reply Last reply
                  0
                  • SolsenS Offline
                    SolsenS Offline
                    Solsen
                    wrote on sidst redigeret af
                    #2097

                    NDA & BLA Application NDA and BLA are applications to market a new product. NDAs are used by CDER (center for drugs) and BLAs are used by CBER (center for biologics) – The BLA requires close scrutiny of the and facilities, because of the greater products. manufacturing process variability of biological – The application will include complete reports on all studies including patient listings, analysis according to the original statistical analysis protocol (SAP) as well as any exploratory analysi

                    1 Reply Last reply
                    0
                    • SolsenS Offline
                      SolsenS Offline
                      Solsen
                      wrote on sidst redigeret af
                      #2098

                      original statistical analysis protocol (SAP) as well as any exploratory analysis.

                      1 Reply Last reply
                      0
                      • MadsSkjernM Offline
                        MadsSkjernM Offline
                        MadsSkjern
                        wrote on sidst redigeret af
                        #2099

                        Opdivo tog fra 26/9 - 22/12 2014 fra accept til approval i melanoma

                        1 Reply Last reply
                        0
                        • SolsenS Offline
                          SolsenS Offline
                          Solsen
                          wrote on sidst redigeret af
                          #2100

                          http://www.slideshare.net/gas25/usfda-nda-vs-bla pkt 30 og frem

                          1 Reply Last reply
                          0
                          • MadsSkjernM Offline
                            MadsSkjernM Offline
                            MadsSkjern
                            wrote on sidst redigeret af
                            #2101

                            Vi kan vel håbe på approval omkring ASH

                            1 Reply Last reply
                            0
                            • SolsenS Offline
                              SolsenS Offline
                              Solsen
                              wrote on sidst redigeret af
                              #2102

                              Rolling submission startede 4. juni som jeg husker - der går ikke frem til ASH med godkendelsen.

                              1 Reply Last reply
                              0
                              • MadsSkjernM Offline
                                MadsSkjernM Offline
                                MadsSkjern
                                wrote on sidst redigeret af
                                #2103

                                Jeg tror man skal slå koldt vand i blodet, de andre

                                1 Reply Last reply
                                0
                                • MadsSkjernM Offline
                                  MadsSkjernM Offline
                                  MadsSkjern
                                  wrote on sidst redigeret af
                                  #2104

                                  tider vide

                                  1 Reply Last reply
                                  0
                                  • MadsSkjernM Offline
                                    MadsSkjernM Offline
                                    MadsSkjern
                                    wrote on sidst redigeret af
                                    #2105

                                    vi taler om er fra accept til approval

                                    1 Reply Last reply
                                    0
                                    • MadsSkjernM Offline
                                      MadsSkjernM Offline
                                      MadsSkjern
                                      wrote on sidst redigeret af
                                      #2106

                                      der er rekorden 2 1/2 måned. Gleevec.

                                      1 Reply Last reply
                                      0
                                      • dingleberryD Offline
                                        dingleberryD Offline
                                        dingleberry
                                        wrote on sidst redigeret af
                                        #2107

                                        gad vide, om ikke vi skal tage "accept/pr" datoen for dara med et gran salt. Som solsen siger, giver rolling submission lidt en "tyvstart" på processen

                                        1 Reply Last reply
                                        0
                                        • SolsenS Offline
                                          SolsenS Offline
                                          Solsen
                                          wrote on sidst redigeret af
                                          #2108

                                          Rolling submission blev valgt af FDA for at få grundlag for hurtigst mulig godkendelse.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger